These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 578811)

  • 1. Rapid control of thyrotoxicosis with combined 131I, anthithyroid drugs and KI therapy.
    Refetoff S; Demeester-Mirkine N; Ermans AM; DeGroot LJ
    J Nucl Med Allied Sci; 1977; 21(1-2):23-9. PubMed ID: 578811
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dosage 131-I therapy of thyrotoxicosis (diffuse goiters). A five-year follow-up study.
    Cevallos JL; Hagen GA; Maloof F; Chapman EM
    N Engl J Med; 1974 Jan; 290(3):141-3. PubMed ID: 4859623
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism.
    Ross DS; Daniels GH; De Stefano P; Maloof F; Ridgway EC
    J Clin Endocrinol Metab; 1983 Aug; 57(2):250-3. PubMed ID: 6688081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
    Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of diffuse toxic goiter].
    Balabolkin MI
    Probl Endokrinol (Mosk); 1986; 32(3):45-8. PubMed ID: 3755532
    [No Abstract]   [Full Text] [Related]  

  • 6. [Basedow's disease. Individual therapy of is great significance].
    Hörmann R
    MMW Fortschr Med; 2005 Sep; 147(35-36):47. PubMed ID: 16180573
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of diffuse toxic goiter with radioactive iodine in combination with prolonged antithyroid therapy].
    Khramtsova VIa; Potin VV; Shliakhtina LG
    Probl Endokrinol (Mosk); 1977; 23(2):48-51. PubMed ID: 71726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotoxicosis.
    Franklyn J
    Clin Med (Lond); 2003; 3(1):11-5. PubMed ID: 12617406
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Graves-Basedow disease].
    Angel M
    Med Clin (Barc); 1988 May; 90(18):748-54. PubMed ID: 2902259
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hyperthyroidism in Grave's disease with low doses of radioactive iodine].
    Wils JA; Kloppenborg PW
    Ned Tijdschr Geneeskd; 1971 Apr; 115(15):657-62. PubMed ID: 5108052
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioiodine uptake after monotherapy with potassium iodide in patients with Graves' disease.
    Mikura K; Yoshimura Noh J; Watanabe N; Aida A; Yoshimura R; Kinoshita A; Suzuki A; Suzuki N; Fukushita M; Matsumoto M; Yoshihara A; Sugino K; Ito K
    Endocr J; 2023 May; 70(5):541-549. PubMed ID: 36843112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diffuse toxic goiter treated with 131I. 30 years' experience].
    Rosas Guzmán J; González Treviño O; Luviano Vázquez C; Maisterrena J
    Rev Invest Clin; 1987; 39(1):11-8. PubMed ID: 3602662
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
    Hegele RA; Volpé R
    J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine-131 treatment of Graves' disease using modified early iodine-131 uptake measurements in therapy dose calculations.
    Hayes AA; Akre CM; Gorman CA
    J Nucl Med; 1990 Apr; 31(4):519-22. PubMed ID: 2324829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simplified method for treating Graves' disease with radioactive 131I.
    Masri MT; Menne M; Rooney BL; Caplan RH
    Wis Med J; 1995 Jan; 94(1):21-5. PubMed ID: 7871797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of aplastic anemia induced by treatment for Graves disease in a pediatric patient.
    Das PK; Wherrett D; Dror Y
    Pediatr Blood Cancer; 2007 Aug; 49(2):210-2. PubMed ID: 16456859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of diffuse hyperthyroidism using radioactive iodine].
    Latković I; Krpan N; Simonović I
    Lijec Vjesn; 1975 Feb; 97(2):72-7. PubMed ID: 1174256
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radioiodine (I-131) treatment of Graves' disease (author's transl)].
    Rösler H; Kinser J
    Ther Umsch; 1973 Oct; 30(10):717-25. PubMed ID: 4800360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.